VRAXVirax Biolabs Group Limited Ordinary Shares
3.190USDMkt Cap: 2.54M $P/E: —3d ago
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the U…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.54M $
Enterprise Value-4.35M $
Revenue (TTM)12.42K $
Gross Profit7.69K $
Net Income (TTM)-5.02M $
Revenue/Share0.0310 USD
Last Price3.190 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.57
PEG—
EV/EBITDA0.72
EV/Revenue-349.99
P/S221.33
P/B0.26
EPS (TTM)-12.64
EPS (Forward)-6.00
52W Range
3.14014% of range3.510
52W High3.510 USD
52W Low3.140 USD
Profitability
Gross Margin61.90%
Oper. Margin-35264.92%
EBITDA Margin0.00%
Profit Margin-40439.10%
ROE-66.30%
ROA-60.35%
Growth
Revenue Growth684.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.62M $
CapEx (TTM)255.83K $
FCF Margin-27988.54%
FCF Yield-136.76%
Net Debt-6.10M $
Net Debt/EBITDA1.01
Balance Sheet
Debt/Equity0.05
Current Ratio9.97
Quick Ratio9.55
Book Value/Sh13.08 USD
Cash/Share11.25 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJun 26, 2026
Analyst Consensus
Rating—
Target (Mean)25.00 USD
Upside (mean)+683.7%
Target Range25.00 USD – 25.00 USD
# Analysts1
Ownership
Shares Out.796.99K
Float529.04K
Insiders2.62%
Institutions3.31%
Short Interest
Short Ratio0.0d
Short % Float4.06%
Short % Out.3.95%
Shares Short31.48K
Short (prev mo.)60.62K
Technical
SMA 503.465 (-7.9%)
SMA 2006.113 (-47.8%)
Beta1.34
S&P 52W Chg21.00%
Avg Vol (30d)112.64K
Avg Vol (10d)1.84M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—